The other seven have no FDA approval and exist only as unregulated research chemicals not meant for human use
When compared to those taking a placebo and with all participants eating a standardized breakfast, people taking semaglutide ate 24% less overall and approximately 35% less during their lunch and evening meals
Full eligibility criteria, including any body mass index thresholds, documentation requirements, or prior authorization conditions, are expected to be communicated directly to beneficiaries through their Part D plan communications as the July 1 launch date approaches
For many people, the side effects can be managed well
The performance of SVC was the worst among the models
Formulary Tier Placement On the 2025-2026 BCBSNC commercial formulary, Wegovy sits on Tier 4 (specialty) for most plans, though some Blue Value and Blue Local plans place it on Tier 3 (non-preferred brand)